X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

CRVS

Closed

Corvus Pharmaceuticals Inc

3.86
-0.14 (-3.50%)
Last Update: 01 Jul 2025 23:21:00
Yesterday: 4.
Day's Range: 3.71 - 4.0386
Send
When Written:
 
0.91
Corvus Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company that develops and commercializes therapies for cancer and other diseases. The company was founded in 2014 and is headquartered in Burlingame, California. Corvus Pharmaceuticals' lead product candidate is CPI-006, a monoclonal antibody that targets CD73, an enzyme that plays a role in suppressing the immune system. The company is also developing other immunotherapy candidates, including CPI-818, which targets T-cell lymphoma, and CPI-0209, which targets cancer-associated fibroblasts. Corvus Pharmaceuticals is focused on developing therapies that can be used alone or in combination with other treatments to improve patient outcomes. The company is publicly traded on the NASDAQ under the ticker symbol CRVS.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X